Source:http://linkedlifedata.com/resource/pubmed/id/17541791
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2007-8-27
|
pubmed:abstractText |
We sought to determine the prevalence of hyperinsulinemia and insulin resistance in pediatric patients with chronic kidney disease (CKD) stages 2-4. Data were collected on 43 subjects, aged 6-21 years with mean glomerular filtration rate (GFR) = 47 ml/min per 1.73 m(2) body surface area. Patients were grouped by body mass index (BMI) as either non-lean (>85th percentile) or lean (<or=85th percentile). Fourteen (33%) subjects had hyperinsulinemia, and seven (16%) had elevated homeostasis model assessment of insulin resistance (HOMA-IR). Non-lean subjects had a higher serum insulin level (21.0 microU/ml vs 13.4 microU/ml, P < 0.0001) and HOMA-IR (4.9 vs 3.2, P < 0.001) than lean subjects had. The prevalence of hyperinsulinemia was higher in non-lean patients (40%) than in lean patients (29%) but was not statistically significant. High HOMA-IR was present in six (40%) non-lean subjects and in one lean subject (P < 0.001). Correlation analysis demonstrated that serum insulin level was significantly associated with BMI, leptin and tumor necrosis factor (TNF)-alpha. Stepwise regression determined that increased BMI (P = 0.003) and TNF-alpha (P = 0.01) independently predicted higher insulin level in the whole cohort. Separate analysis for lean subjects showed no significant associations between serum insulin level and BMI; TNF-alpha was the only independent predictor of serum insulin (beta = 1.11, P = 0.01). We conclude that hyperinsulinemia and insulin resistance are frequent in pediatric CKD. In lean patients inflammation appears to be an important determinant of serum insulin level.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0931-041X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1751-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17541791-Adiponectin,
pubmed-meshheading:17541791-Adolescent,
pubmed-meshheading:17541791-Adult,
pubmed-meshheading:17541791-Body Mass Index,
pubmed-meshheading:17541791-Child,
pubmed-meshheading:17541791-Glomerular Filtration Rate,
pubmed-meshheading:17541791-Humans,
pubmed-meshheading:17541791-Hyperinsulinism,
pubmed-meshheading:17541791-Insulin,
pubmed-meshheading:17541791-Insulin Resistance,
pubmed-meshheading:17541791-Kidney Failure, Chronic,
pubmed-meshheading:17541791-Leptin,
pubmed-meshheading:17541791-Prevalence,
pubmed-meshheading:17541791-Regression Analysis,
pubmed-meshheading:17541791-Tumor Necrosis Factor-alpha
|
pubmed:year |
2007
|
pubmed:articleTitle |
Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor-alpha.
|
pubmed:affiliation |
Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, MLC 7022, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA.
|
pubmed:publicationType |
Journal Article
|